European Advanced Wound Care Market by Method, by Application, by End user – Analysis and Forecast to 2019

The Europe Advanced Wound Care Market is estimated to grow at a CAGR of 3.7% from 2014 to 2019. Germany holds the largest share in this market, and is expected to grow at a CAGR of 2.9% in the forecast period.

In this report, the Europe advance wound care market has been broadly classified on the basis of application, method, geography, and end-user. The application segment is divided into surgical wounds, ulcers, and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers, and arterial ulcers. The method segment includes dressings and grafts, where dressings are further categorized into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, alginate dressings; and grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts include autografts, allografts and xenografts. The geography segment includes Germany, U.K., Italy, France, Spain, and Rest of Europe (RoE). The end-user segment includes in-patient facilities and out-patient facilities.

Grafts is the fastest growing segment, which is estimated to grow at the highest CAGR from 2014 to 2019. Factors like rising incidences of chronic wounds due to aging population, increasing incidences of diabetes, and a change in lifestyles are driving the growth of this market.

The Europe advanced wound care market is a competitive market with a number of market players. As of 2014, this market is majorly dominated by Smith and Nephew, Plc. (U.K.), Molyncke Health Care (Sweden), and ConvaTec, Inc. (U.S.).

New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, such as industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the Europe advanced wound care market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, inhibitors, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) to strengthen their market share.



The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on top players in the advanced wound care market is provided

‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the advanced wound care market are provided

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various advanced wound care market
across geographies

‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the advanced wound care market is provided

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the advanced wound care market is provided

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET SEGMENTATION & COVERAGE 15
1.3 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 INTEGRATED ECOSYSTEM OF THE ADVANCED WOUND CARE MARKET 17
2.2 ARRIVING AT THE ADVANCED WOUND CARE MARKET SIZE 18
2.2.1 TOP-DOWN APPROACH 19
2.2.2 BOTTOM-UP APPROACH 20
2.2.3 MACROINDICATOR-BASED APPROACH 21
2.3 ASSUMPTIONS 22
3 EXECUTIVE SUMMARY 23
4 MARKET OVERVIEW 24
4.1 INTRODUCTION 24
4.2 EUROPEAN ADVANCED WOUND CARE MARKET: COMPARISON WITH PARENT MARKET 25
4.3 MARKET DRIVERS AND INHIBITORS 26
4.4 KEY MARKET DYNAMICS 27
5 EUROPEAN ADVANCED WOUND CARE MARKET, BY APPLICATION 39
5.1 INTRODUCTION 40
5.2 EUROPE: ADVANCED WOUND CARE MARKET, BY APPLICATION 41
5.3 EUROPE: ADVANCED WOUND CARE MARKET FOR ULCERS, BY APPLICATION 42
5.4 EUROPE: ADVANCED WOUND CARE MARKET FOR SURGICAL WOUNDS, BY COUNTRY 43
5.5 EUROPE: ADVANCED WOUND CARE MARKET FOR ULCERS, BY COUNTRY 45
5.6 EUROPE: ADVANCED WOUND CARE MARKET FOR OTHER WOUNDS, BY COUNTRY 46
6 EUROPEAN ADVANCED WOUND CARE MARKET, BY METHOD 48
6.1 INTRODUCTION 49
6.2 EUROPE: ADVANCED WOUND CARE MARKET, BY METHOD 50
6.3 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 51
6.4 EUROPE: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 53
6.5 EUROPE: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 54
6.6 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY 56
6.7 EUROPE: ADVANCED WOUND CARE GRAFTS MARKET, BY COUNTRY 57
7 EUROPEAN ADVANCED WOUND CARE MARKET, BY COUNTRY 59
7.1 INTRODUCTION 60
7.2 GERMANY: ADVANCED WOUND CARE MARKET 61
7.2.1 GERMANY: ADVANCED WOUND CARE MARKET, BY APPLICATION 62
7.2.2 GERMANY: ADVANCED WOUND CARE MARKET FOR ULCERS, BY TYPE 63
7.2.3 GERMANY: ADVANCED WOUND CARE MARKET, BY METHOD 64
7.2.4 GERMANY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 65
7.2.5 GERMANY: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 66
7.2.6 GERMANY: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 67
7.2.7 GERMANY: ADVANCED WOUND CARE MARKET, BY END USER 68
7.3 FRANCE: ADVANCED WOUND CARE MARKET 69
7.3.1 FRANCE: ADVANCED WOUND CARE MARKET, BY APPLICATION 70
7.3.2 FRANCE: ADVANCED WOUND CARE MARKET FOR ULCERS, BY TYPE 71
7.3.3 FRANCE: ADVANCED WOUND CARE MARKET, BY METHOD 72
7.3.4 FRANCE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 73
7.3.5 FRANCE: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 74
7.3.6 FRANCE: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 75
7.3.7 FRANCE: ADVANCED WOUND CARE MARKET, BY END USER 76
7.4 U.K.: ADVANCED WOUND CARE MARKET 77
7.4.1 U.K.: ADVANCED WOUND CARE MARKET, BY APPLICATION 78
7.4.2 U.K.: ADVANCED WOUND CARE MARKET FOR ULCERS, BY TYPE 79
7.4.3 U.K.: ADVANCED WOUND CARE MARKET, BY METHOD 80
7.4.4 U.K.: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 81
7.4.5 U.K.: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 82
7.4.6 U.K.: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 83
7.4.7 U.K.: ADVANCED WOUND CARE MARKET, BY END USER 84
7.5 ITALY: ADVANCED WOUND CARE MARKET 85
7.5.1 ITALY: ADVANCED WOUND CARE MARKET, BY APPLICATION 86
7.5.2 ITALY: ADVANCED WOUND CARE MARKET FOR ULCERS, BY TYPE 87
7.5.3 ITALY: ADVANCED WOUND CARE MARKET, BY METHOD 88
7.5.4 ITALY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 89
7.5.5 ITALY: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 90
7.5.6 ITALY: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 91
7.5.7 ITALY: ADVANCED WOUND CARE MARKET, BY END USER 92
7.6 SPAIN: ADVANCED WOUND CARE MARKET 93
7.6.1 SPAIN: ADVANCED WOUND CARE MARKET, BY APPLICATION 94
7.6.2 SPAIN: ADVANCED WOUND CARE MARKET FOR ULCERS, BY TYPE 95
7.6.3 SPAIN: ADVANCED WOUND CARE MARKET, BY METHOD 96
7.6.4 SPAIN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE 97
7.6.5 SPAIN: ADVANCED WOUND CARE GRAFTS MARKET, BY TYPE 98
7.6.6 SPAIN: ADVANCED WOUND CARE BIOLOGIC GRAFTS MARKET, BY TYPE 99
7.6.7 SPAIN: ADVANCED WOUND CARE MARKET, BY END USER 100
8 EUROPEAN ADVANCED WOUND CARE MARKET, BY END USER 101
8.1 INTRODUCTION 102
8.2 EUROPE: ADVANCED WOUND CARE MARKET FOR INPATIENT FACILITIES, BY COUNTRY 103
8.3 EUROPE: ADVANCED WOUND CARE MARKET FOR OUTPATIENT FACILITIES,
BY COUNTRY 104
9 EUROPEAN ADVANCED WOUND CARE MARKET: COMPETITIVE LANDSCAPE 106
9.1 EUROPEAN ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 106
9.2 MERGERS & ACQUISITIONS 108
9.3 NEW PRODUCT LAUNCHES 109
10 EUROPE: ADVANCED WOUND CARE MARKET, BY COMPANY 110
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 SMITH AND NEPHEW, PLC. 110
10.2 INTEGRA LIFE SCIENCES CORPORATION 113
10.3 MOLYNCKE HEALTH CARE 115
10.4 CONVATEC, INC. 117
10.5 COLOPLAST GROUP 120
10.6 ORGANOGENESIS, INC. 122
10.7 MEDLINE INDUSTRIES, INC. 123
10.8 SHIRE, PLC. 125
10.9 MIMEDX GROUP, INC. 126
10.10 LABORATORIES URGO 128
10.11 SYSTAGENIX 129
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 APPENDIX 131
11.1 CUSTOMIZATION OPTIONS 131
11.1.1 SUPPLY CHAIN ANALYSIS 131
11.1.2 IMPACT ANALYSIS 131
11.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 132
11.2.1 RT SNAPSHOTS 133